SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739,200 | +7.1% | 6,098 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $690,212 | -17.9% | 6,027 | -1.2% | 0.00% | -33.3% |
| Q1 2023 | $840,763 | -24.5% | 6,100 | -29.0% | 0.00% | -25.0% |
| Q4 2022 | $1,113,222 | +15.0% | 8,591 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $968,000 | +56.6% | 8,761 | +6.2% | 0.00% | +100.0% |
| Q2 2022 | $618,000 | -28.1% | 8,249 | -25.0% | 0.00% | 0.0% |
| Q1 2022 | $859,000 | -34.0% | 11,002 | -23.9% | 0.00% | -33.3% |
| Q4 2021 | $1,301,000 | -25.8% | 14,450 | -23.8% | 0.00% | -40.0% |
| Q3 2021 | $1,753,000 | +30.9% | 18,952 | +10.1% | 0.01% | +25.0% |
| Q2 2021 | $1,339,000 | +44.8% | 17,218 | +38.7% | 0.00% | +33.3% |
| Q1 2021 | $925,000 | -60.1% | 12,411 | -8.7% | 0.00% | -66.7% |
| Q4 2020 | $2,319,000 | +17.9% | 13,600 | -2.9% | 0.01% | 0.0% |
| Q3 2020 | $1,967,000 | -10.2% | 14,009 | +2.6% | 0.01% | -25.0% |
| Q2 2020 | $2,190,000 | +93.6% | 13,657 | +18.2% | 0.01% | +50.0% |
| Q1 2020 | $1,131,000 | -50.8% | 11,558 | -35.1% | 0.01% | -27.3% |
| Q4 2019 | $2,298,000 | +40.0% | 17,812 | -18.2% | 0.01% | +22.2% |
| Q3 2019 | $1,641,000 | -53.8% | 21,785 | -6.7% | 0.01% | -57.1% |
| Q2 2019 | $3,549,000 | +10.8% | 23,354 | -13.1% | 0.02% | +10.5% |
| Q1 2019 | $3,204,000 | +13.6% | 26,883 | +4.0% | 0.02% | -5.0% |
| Q4 2018 | $2,821,000 | -40.4% | 25,850 | -11.8% | 0.02% | -37.5% |
| Q3 2018 | $4,732,000 | +30.0% | 29,301 | +6.4% | 0.03% | +33.3% |
| Q2 2018 | $3,640,000 | +30.3% | 27,538 | -26.9% | 0.02% | +33.3% |
| Q1 2018 | $2,793,000 | +14.4% | 37,696 | -14.1% | 0.02% | +5.9% |
| Q4 2017 | $2,442,000 | +33.6% | 43,894 | +8.9% | 0.02% | 0.0% |
| Q3 2017 | $1,828,000 | +65.3% | 40,302 | +22.9% | 0.02% | +54.5% |
| Q2 2017 | $1,106,000 | +6.7% | 32,799 | -6.4% | 0.01% | 0.0% |
| Q1 2017 | $1,037,000 | -14.3% | 35,026 | -20.6% | 0.01% | -15.4% |
| Q4 2016 | $1,210,000 | -43.8% | 44,119 | +25.9% | 0.01% | -56.7% |
| Q3 2016 | $2,152,000 | +187.3% | 35,039 | -10.8% | 0.03% | +200.0% |
| Q2 2016 | $749,000 | -2.3% | 39,296 | +0.0% | 0.01% | -9.1% |
| Q1 2016 | $767,000 | -53.7% | 39,286 | -8.5% | 0.01% | -45.0% |
| Q4 2015 | $1,656,000 | +44.8% | 42,922 | +20.5% | 0.02% | +25.0% |
| Q3 2015 | $1,144,000 | -2.0% | 35,621 | -7.1% | 0.02% | 0.0% |
| Q2 2015 | $1,167,000 | +113.7% | 38,364 | -6.8% | 0.02% | +166.7% |
| Q1 2015 | $546,000 | +4.6% | 41,145 | +14.0% | 0.01% | 0.0% |
| Q4 2014 | $522,000 | -33.6% | 36,093 | -3.1% | 0.01% | -40.0% |
| Q3 2014 | $786,000 | -40.7% | 37,245 | -16.3% | 0.01% | -41.2% |
| Q2 2014 | $1,326,000 | -17.4% | 44,519 | -33.4% | 0.02% | -15.0% |
| Q1 2014 | $1,606,000 | +308.7% | 66,834 | +246.4% | 0.02% | +233.3% |
| Q4 2013 | $393,000 | -74.7% | 19,292 | -41.5% | 0.01% | -83.8% |
| Q3 2013 | $1,556,000 | +573.6% | 32,955 | +441.9% | 0.04% | +640.0% |
| Q2 2013 | $231,000 | – | 6,081 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |